Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase

Release time：Jan 02, 2024

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, President of R&D of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase in San Francisco, United States. Dr. Hai Wu will introduce Mabwell's global collaboration strategy, innovative pipeline covering therapeutic areas of oncology, autoimmune and central nervous system, as well as ADC innovative technology platform IDDC™. The R&D and BD team will have in-depth exchanges with multinational pharmaceutical companies and bio-techs to accelerate the expansion of global partnerships.

Presentation information at Biotech Showcase:

Time: Jan 9th, 2024 9:30 am (Pacific Time Zone)

Track: Hilton San Francisco - Union Square 333 O'Farrell Street, Yosemite C (Ballroom Level), San Francisco, CA 94102

About J.P. Morgan Healthcare Conference

The J.P. Morgan Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

About Biotech Showcase

Biotech Showcase is dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies with the opportunity to present to and connect with investors and biopharmaceutical executives.

Hot News